XML 60 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share Based Compensation [Abstract]  
Schedule of Share-Based Compensation Expense

The table below sets forth the line items where share-based compensation expense was recorded for the twelve months ended December 31:

 

 

 

2020

 

 

2019

 

 

2018

 

Cost of goods sold

 

$

1,064

 

 

$

925

 

 

$

362

 

Selling, general and administrative expense

 

 

21,013

 

 

 

16,687

 

 

 

17,395

 

Research and development expense

 

 

3,183

 

 

 

2,923

 

 

 

2,979

 

Total share-based compensation expense

 

$

25,260

 

 

$

20,535

 

 

$

20,736

 

Schedule of Share-Based Compensation Expense by Type

 

The table below sets forth share-based compensation expense by type for the twelve months ended December 31:

 

 

 

2020

 

 

2019

 

 

2018

 

Stock options

 

$

-

 

 

$

-

 

 

$

274

 

Share grants

 

 

25,260

 

 

 

20,535

 

 

 

20,462

 

Total share-based compensation expense

 

$

25,260

 

 

$

20,535

 

 

$

20,736

 

Schedule of Share Based Compensation Stock Options Activity

The table below sets forth a summary of activity in our stock option plan: 

Stock Options

 

Shares

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Remaining

Contractual Term

(years)

 

 

Aggregate

Intrinsic Value

 

Outstanding at December 31, 2017

 

 

1,228

 

 

 

22.85

 

 

 

 

 

 

 

 

 

Exercised

 

 

(240

)

 

 

20.28

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

988

 

 

 

23.47

 

 

 

 

 

 

$

8,693

 

Exercised

 

 

(524

)

 

 

22.68

 

 

 

 

 

 

$

10,600

 

Outstanding and Exercisable  at December 31, 2019

 

 

464

 

 

 

24.37

 

 

 

 

 

 

$

14,849

 

Exercised

 

 

(272

)

 

 

25.11

 

 

 

 

 

 

$

8,278

 

Outstanding and Exercisable  at December 31, 2020

 

 

192

 

 

 

23.32

 

 

 

1.4

 

 

$

9,059

 

 

 

Schedule of Stock Options Outstanding

The table below sets forth information about stock options outstanding at December 31, 2020:

 

Plan

 

Range of Exercise Prices

 

Number Exercisable

 

 

Weighted Average Remaining Contractual Life

(Years)

 

 

Weighted Average Exercise Price

 

2001 Plan

 

18.48 - 19.27

 

 

102

 

 

 

1.4

 

 

$

19.25

 

2013 Plan

 

27.92

 

 

90

 

 

 

1.4

 

 

27.92

 

Summary of Nonvested Share Grants

The table below sets forth a summary of our non-vested share grants in 2020, 2019 and 2018:

Nonvested at December 31, 2017

 

 

2,280

 

 

 

22.24

 

 

 

 

 

Granted

 

 

646

 

 

 

32.06

 

 

 

 

 

Vested

 

 

(1,213

)

 

 

21.39

 

 

 

 

 

Forfeited

 

 

(46

)

 

 

24.72

 

 

 

 

 

Nonvested at December 31, 2018

 

 

1,667

 

 

 

26.68

 

 

 

 

 

Granted

 

 

670

 

 

 

38.15

 

 

 

 

 

Vested

 

 

(573

)

 

 

24.90

 

 

 

 

 

Forfeited

 

 

(67

)

 

 

30.44

 

 

 

 

 

Nonvested at December 31, 2019

 

 

1,697

 

 

 

31.71

 

 

 

 

 

Granted

 

 

573

 

 

 

48.83

 

 

 

 

 

Vested

 

 

(770

)

 

 

27.78

 

 

$

37,620

 

Forfeited and other

 

 

88

 

 

 

38.31

 

 

 

 

 

Nonvested at December 31, 2020

 

 

1,588

 

 

 

39.30

 

 

$

111,947